Dr. Dinesh S. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Dinesh S. Patel, on behalf of himself and the promoter/promoter group of Gujarat Themis Biosyn, has submitted a declaration under SEBI Takeover Regulations stating that no new encumbrance (pledge or charge) was created on their shares during the financial year ended 31st March 2025. The promoter group includes 7 individuals/entities such as Jayshree Patel, Sachin Patel, Reena Patel, the Choksi family, and two promoter-group companies — Pharmaceutical Business Group (India) Ltd and Themis Medicare Limited. The letter also references that prior disclosures regarding shares of Pharmaceutical Business Group (India) Ltd that were pledged in FY 2023-24 had already been filed with BSE.
This is a routine compliance filing confirming that the promoter group did not create any new pledges or encumbrances on their holdings in FY25, which is broadly neutral and reassuring for shareholders as it signals no incremental pledging risk from the promoter group this year.